If there is one terpene worth understanding before any other, it is myrcene. It is the most abundant terpene found in modern cannabis cultivars, present in significant concentrations in the majority of strains sold at dispensaries worldwide — and in Thailand. It is responsible for the earthy, musky character that defines classic cannabis aroma. And it is, according to a growing body of pharmacological research, a genuinely bioactive compound with measurable effects on the human nervous system.
This is a detailed look at what myrcene is, how it is made, how it works in the body, and what that means for the cannabis consumer.
The Chemistry of Myrcene
Myrcene (pronounced MUR-seen) is classified as an acyclic monoterpene. "Acyclic" means its carbon chain does not form a ring — it remains open — which distinguishes it structurally from terpenes like pinene (bicyclic) or terpinolene (monocyclic). "Monoterpene" places it in the class of terpenes built from two isoprene units, giving it the molecular formula C₁₀H₁₆ and a molecular weight of 136.23 g/mol.
The most commonly encountered form in cannabis is β-myrcene (beta-myrcene), an oily, colourless liquid at room temperature with a boiling point of approximately 167°C (333°F). This is relevant to consumption: when vaporising cannabis, temperatures below this point will not fully volatilise myrcene, while combustion at 200°C+ causes rapid degradation. Vaporising in the 170–185°C range captures myrcene at its most intact.
Myrcene is also found throughout the natural world. Notable non-cannabis sources include:
- Hops (Humulus lupulus): Myrcene is the primary terpene responsible for the fresh, resinous character of dry-hopped beer. Cannabis and hops are botanical relatives — both belong to the family Cannabaceae.
- Mango (Mangifera indica): Ripe mangoes contain myrcene in their skin and pulp, which is the botanical basis of the so-called "mango trick."
- Lemongrass (Cymbopogon citratus): A widely used herb across Southeast Asia, including Thai cuisine, lemongrass essential oil is approximately 20–25% myrcene.
- Thyme, bay leaves, and verbena also contain meaningful concentrations.
How Myrcene Is Made: Biosynthesis in the Cannabis Plant
Understanding how cannabis produces myrcene requires a brief look at plant biochemistry. Terpene synthesis in cannabis occurs primarily in the trichomes — the microscopic, resin-secreting glands on the surface of the flower. Within these structures, myrcene is synthesised through the methylerythritol phosphate (MEP) pathway, also called the plastidic pathway.
The sequence works like this:
- The MEP pathway converts pyruvate and glyceraldehyde-3-phosphate (intermediates of glucose metabolism) into two five-carbon building blocks: isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP).
- These two molecules combine, head-to-tail, to form geranyl pyrophosphate (GPP) — the universal 10-carbon precursor to all monoterpenes.
- The enzyme myrcene synthase (a terpene synthase, or "TPS" enzyme) then catalyses a single-step conversion of GPP to myrcene, releasing pyrophosphate as a byproduct.
The genetics of individual cannabis cultivars determine how much myrcene synthase is expressed, which is why myrcene content varies enormously between strains — from negligible traces to over 1.5% of total flower weight in some indica-dominant cultivars. Myrcene concentrations above approximately 0.5% are generally considered high enough to be pharmacologically significant.
How Myrcene Affects the Body: Receptor Mechanisms
This is where the science becomes particularly interesting. Myrcene is not simply a passive fragrance molecule. It interacts with the human nervous system through several distinct mechanisms, each supported to varying degrees by peer-reviewed research.
GABA-A Receptor Modulation
The most significant and well-supported mechanism is myrcene's interaction with GABA-A receptors. GABA (gamma-aminobutyric acid) is the primary inhibitory neurotransmitter in the central nervous system. When GABA-A receptors are activated, neuronal activity slows — producing relaxation, reduced anxiety, and at sufficient levels, sedation and sleep. Benzodiazepines (diazepam, lorazepam) and alcohol work through this same system.
A pivotal 2002 study by Rao et al., conducted in mice, demonstrated that myrcene produced significant sedative and motor-depressant effects. Critically, these effects were substantially reduced when subjects were pre-treated with flumazenil — a GABA-A receptor antagonist used clinically to reverse benzodiazepine overdose. The reversal with flumazenil is strong pharmacological evidence that myrcene's sedative action is at least partially mediated through GABA-A receptor modulation, specifically as a positive allosteric modulator — meaning it enhances the receptor's response to GABA rather than directly activating it.
This mechanism provides the most scientifically coherent explanation for why high-myrcene cannabis strains consistently produce more pronounced sedation than lower-myrcene cultivars at equivalent THC levels.
Interaction with the Opioid System
Research into myrcene's analgesic (pain-relieving) properties has pointed to a second, distinct mechanism: interaction with the endogenous opioid system. A 1991 study by Lorenzetti et al. demonstrated meaningful analgesic effects of myrcene in rodent models. When subjects were pre-treated with naloxone — an opioid receptor antagonist used clinically to reverse opioid overdose — myrcene's analgesic effects were significantly attenuated.
This naloxone-reversibility is the pharmacological signature of opioid receptor involvement, pointing specifically to μ-opioid (mu-opioid) receptor engagement. The endogenous opioid system regulates pain, stress responses, and reward — it is the same system activated by endorphins during exercise. Myrcene's interaction here is far weaker than pharmaceutical opioids, but it contributes to a multi-modal analgesic effect.
The combination of GABA-A modulation (sedation, anxiolysis) and opioid system engagement (analgesia, mild euphoria) working in parallel goes a long way toward explaining why high-myrcene cannabis is repeatedly described as producing heavy, body-focused relaxation with effective pain relief.
Blood-Brain Barrier Permeability
A third mechanism has significant implications for how myrcene affects the overall cannabis experience. Research suggests that myrcene may increase the permeability of the blood-brain barrier — the selective membrane that controls which molecules pass from the bloodstream into the central nervous system.
If this effect is real and significant in humans (it has been demonstrated in cell studies and animal models), it would mean that myrcene-rich cannabis facilitates faster and more extensive THC uptake into the brain, producing a more rapid onset and potentially more intense psychoactive effect than the THC content alone would predict. This is a plausible mechanism for the widely observed phenomenon that high-myrcene strains "hit harder and faster" than lower-myrcene strains at equivalent THC percentages.
α2-Adrenergic Receptor Activity
Some research suggests myrcene may also interact with α2-adrenergic receptors, which are involved in regulating the sympathetic nervous system. Activation of these receptors decreases sympathetic output — heart rate drops, blood pressure lowers, and the body shifts toward a parasympathetic ("rest and digest") state. This would contribute to myrcene's muscle-relaxant properties and its characteristic feeling of physical heaviness.
Anti-Inflammatory Mechanisms
Myrcene's anti-inflammatory action appears to operate through inhibition of prostaglandin E1 and E2 (PGE-1, PGE-2) — lipid signalling molecules that sensitise pain receptors and drive the inflammatory response. This is distinct from the mechanism of NSAIDs like ibuprofen, which inhibit the COX enzymes upstream. Studies, including work published by Figueiredo et al., have demonstrated that myrcene reduces inflammatory cytokine production and attenuates acute inflammation in animal models.
The "Mango Trick" — What the Science Actually Says
The claim circulating in cannabis culture is simple: eat a ripe mango 45 minutes before consuming cannabis and the experience will be stronger and longer-lasting. The proposed mechanism is that the myrcene in the mango primes the blood-brain barrier and the nervous system, amplifying THC's effects.
The science is more nuanced. Ripe mangoes do contain myrcene — primarily in the skin and the volatile compounds near it — but the concentrations in flesh consumed during eating are relatively modest. Whether the plasma myrcene levels achievable by eating one or two mangoes are pharmacologically meaningful in humans has not been rigorously studied in clinical trials.
What the science does support is this: myrcene has demonstrated blood-brain barrier effects and GABA-A modulating activity at sufficient concentrations, and mangoes genuinely contain myrcene. The mango trick is biologically plausible. Whether it produces a noticeable effect will depend on the individual, the ripeness and variety of the mango, and the myrcene content of the cannabis consumed. The effect, if real, is likely subtle for most people — more of an incremental enhancement than a transformation.
Myrcene and the Indica/Sativa Framework
One of the more useful applications of myrcene science is in understanding why the indica/sativa classification, while imprecise, isn't entirely useless. Studies of the terpene profiles of commercially labelled indica and sativa strains have consistently found that indica-labelled strains tend to have significantly higher myrcene concentrations than sativa-labelled ones.
Given myrcene's GABA-A modulation, opioid system engagement, and BBB effects, this provides a plausible biochemical explanation for the experiential difference between indica and sativa — not in the plant's genetics per se, but in its terpene chemistry. A "sativa" strain with low myrcene and high terpinolene will predictably feel different from an "indica" with dominant myrcene, even at identical THC levels. The terpene profile, with myrcene as the key variable, does more explanatory work than the genetic lineage label.
Strains Where Myrcene Dominates
The following strains are consistently among the highest in myrcene concentration and are widely available at quality dispensaries in Thailand:
- OG Kush (Hybrid): One of the defining myrcene-dominant cultivars. Earthy, pungent, with petrol and pine notes. Produces a heavy, euphoric relaxation with strong analgesic properties — a textbook expression of myrcene's pharmacology at work.
- Granddaddy Purple (Indica): Sweet grape and berry aroma overlaid on an earthy myrcene base. Deep physical sedation, commonly used for sleep and chronic pain.
- Blue Dream (Sativa-dominant Hybrid): An instructive example of myrcene in a sativa-dominant context. The blueberry sweetness comes from other terpenes; the grounding, relaxing undertone is myrcene. Less sedating than a pure indica despite high myrcene, because other terpenes modulate the effect.
- White Widow (Hybrid): Earthy and woody, with myrcene providing the characteristic weight beneath an otherwise alert effect profile.
- Grape Ape (Indica): Grape, berry, and earthy — one of the highest-myrcene strains tested, with concentrations sometimes exceeding 1% of flower weight.
What to Look For When Buying
If you are seeking a myrcene-dominant strain at a Thai dispensary, ask directly for the terpene breakdown. Any dispensary with proper lab-tested stock should be able to provide it. Practically, strains described as earthy, musky, herbal, or mango-like are strong candidates. Classic indica-labelled cultivars with high THC and strong sedating reputations are where myrcene most reliably dominates.
For evening use, pain management, muscle tension, or sleep: myrcene is the terpene to prioritise. For daytime use or any context where mental clarity matters, you're looking at a different terpene profile entirely — limonene, pinene, or terpinolene.
Explore Strains on Dispensary Thailand
Use our strain search to find myrcene-rich strains currently in stock at dispensaries near you. For the most accurate picture, look for dispensaries that list full terpene data alongside THC and CBD percentages — these are the operators taking product knowledge seriously.